JPMORGAN CHASE & CO - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 97 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$286,000
-95.7%
272,163
-92.0%
0.00%
-100.0%
Q2 2019$6,729,000
-52.3%
3,381,146
-19.3%
0.00%
-66.7%
Q1 2019$14,120,000
+21.0%
4,190,020
+4.9%
0.00%0.0%
Q4 2018$11,667,000
-51.1%
3,995,794
+3.1%
0.00%
-40.0%
Q3 2018$23,866,000
-9.5%
3,874,395
+8.4%
0.01%0.0%
Q2 2018$26,374,000
+40.4%
3,573,579
+24.8%
0.01%
+25.0%
Q1 2018$18,782,000
-4.5%
2,863,044
+22.4%
0.00%0.0%
Q4 2017$19,672,000
-24.9%
2,339,068
+3.4%
0.00%
-33.3%
Q3 2017$26,184,000
-9.1%
2,263,108
-8.3%
0.01%
-14.3%
Q2 2017$28,811,000
+4.3%
2,466,752
+10.2%
0.01%
+16.7%
Q1 2017$27,630,000
-4.5%
2,239,084
+5.4%
0.01%
-14.3%
Q4 2016$28,937,000
-34.9%
2,124,601
-4.9%
0.01%
-36.4%
Q3 2016$44,459,000
+45.6%
2,234,064
-5.2%
0.01%
+37.5%
Q2 2016$30,527,000
+33.9%
2,355,386
-3.4%
0.01%
+33.3%
Q1 2016$22,797,000
-38.2%
2,438,169
+33.9%
0.01%
-33.3%
Q4 2015$36,918,000
+113.2%
1,821,287
+52.8%
0.01%
+80.0%
Q3 2015$17,316,000
-11.9%
1,191,668
+28.9%
0.01%0.0%
Q2 2015$19,660,000
-1.9%
924,357
+6.9%
0.01%0.0%
Q1 2015$20,036,000
+74.8%
864,699
+73.8%
0.01%
+66.7%
Q4 2014$11,464,000497,5730.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
EMORY UNIVERSITY 95,215$1,297,0001.28%
Baker Brothers Advisors 4,865,647$66,270,0000.65%
Eventide Asset Management 250,000$3,405,0000.22%
MCDANIEL TERRY & CO 76,112$1,037,0000.22%
SUFFOLK CAPITAL MANAGEMENT LLC 82,538$1,124,0000.15%
QVT Financial LP 337,923$4,603,0000.14%
KENNEDY CAPITAL MANAGEMENT LLC 478,465$6,517,0000.11%
Vident Investment Advisory, LLC 47,157$642,0000.08%
Tekla Capital Management LLC 60,000$817,0000.04%
First Eagle Investment Management, LLC 775,254$10,559,0000.03%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders